NYSE: UNHUnitedhealth Group Inc Stock Forecast, Predictions & Price Target
Analyst price target for UNH
Based on 18 analysts offering 12 month price targets for Unitedhealth Group Inc.
Min Forecast
$300.00-7.06%
Avg Forecast
$351.28+8.83%
Max Forecast
$385.00+19.27%
Should I buy or sell UNH stock?
Strong Buy
Strong Buy
14 analysts 77.78%
Buy
1 analysts 5.56%
Hold
3 analysts 16.67%
Sell
0 analysts 0.00%
Strong Sell
0 analysts 0.00%
Forecast return on equity
Is UNH forecast to generate an efficient return?
Company
31.08%
Industry
33.48%
Market
13.94%
UNH's Return on Equity is forecast to be high in 3 years (31.08%); analysts are confident in the firm's ability to efficiently generate return on equity
Forecast
Forecast return on assets
Is UNH forecast to generate an efficient return on assets?
Company
10.27%
Industry
7.59%
Market
10.01%
UNH is forecast to generate higher Return on Assets (10.27%) than the US Healthcare industry average (7.59%)
Forecast
UNH earnings per share forecast
What is UNH's earnings per share in the next 3 years based on estimates from 11 analysts?
Avg 1 year Forecast
$16.78-6.80%
Avg 2 year Forecast
$18.34+1.85%
Avg 3 year Forecast
$20.86+15.82%
UNH's earnings are forecast to grow at a rate of 1.65% per year, which is not exceptional
Forecast
UNH revenue forecast
What is UNH's revenue in the next 3 years based on estimates from 8 analysts?
Avg 1 year Forecast
$256.3B+3.42%
Avg 2 year Forecast
$279.0B+12.60%
Avg 3 year Forecast
$303.4B+22.43%
UNH's revenue is forecast to grow at a rate of 6.21% per year, which is not exceptional
Forecast
UNH earnings growth forecast
How is UNH forecast to perform vs Healthcare companies and vs the US market?
Company
1.65%
Industry
23.73%
Market
15.17%
UNH's earnings are forecast to grow slower (1.65% per year) than the US Healthcare industry average (23.73%)
Forecast
UNH's earnings are forecast to grow slower (1.65% per year) than the US market average (15.17%)
Forecast
UNH revenue growth forecast
How is UNH forecast to perform vs Healthcare companies and vs the US market?
Company
6.21%
Industry
18.34%
Market
3.03%
UNH's revenues are forecast to grow slower (6.21% per year) than the US Healthcare industry average (18.34%)
Forecast
UNH's revenues are forecast to grow faster (6.21% per year) than the US market average (3.03%)
Forecast
Unitedhealth Group Stock Forecast FAQ
Is Unitedhealth Group Stock a good buy in 2020, according to Wall Street analysts?
The consensus among 18 Wall Street analysts covering (NYSE: UNH) stock is to Strong Buy UNH stock.
Out of 18 analysts, 14 (77.78%) are recommending UNH as a Strong Buy, 1 (5.56%) are recommending UNH as a Buy, 3 (16.67%) are recommending UNH as a Hold, 0 (0.00%) are recommending UNH as a Sell, and 0 (0.00%) are recommending UNH as a Strong Sell.
What is UNH's Price Target?
According to 18 Wall Street analysts that have issued a 1 year UNH price target, the average UNH price target is $351.28, with the highest UNH stock price forecast at $385.00 and the lowest UNH stock price forecast at $300.00.
On average, Wall Street analysts predict that Unitedhealth Group's share price could reach $351.28 by Oct 19, 2021. The average Unitedhealth Group stock price prediction forecasts a potential upside of 8.62% from the current UNH share price of $323.41.
What is UNH's earnings growth forecast for 2020-2022?
(NYSE: UNH) Unitedhealth Group's forecast annual earnings growth rate of 1.65% is not forecast to beat the US Healthcare industry's average forecast earnings growth rate of 23.73%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 15.17%.
Unitedhealth Group's earnings in 2020 is $17,098,000,000.On average, 11 Wall Street analysts forecast UNH's earnings for 2020 to be $15,918,075,751, with the lowest UNH earnings forecast at $15,790,518,708, and the highest UNH earnings forecast at $16,255,224,664. On average, 13 Wall Street analysts forecast UNH's earnings for 2021 to be $17,396,883,909, with the lowest UNH earnings forecast at $16,122,451,534, and the highest UNH earnings forecast at $17,782,115,663.
In 2022, UNH is forecast to generate $19,781,963,518 in earnings, with the lowest earnings forecast at $18,730,495,165 and the highest earnings forecast at $20,153,064,418.
What is UNH's revenue growth forecast for 2020-2022?
(NYSE: UNH) Unitedhealth Group's forecast annual revenue growth rate of 6.21% is not forecast to beat the US Healthcare industry's average forecast revenue growth rate of 18.34%, and while it is forecast to beat the US market's average forecast revenue growth rate of 3.03%.
Unitedhealth Group's revenue in 2020 is $247,811,000,000.On average, 8 Wall Street analysts forecast UNH's revenue for 2020 to be $243,059,608,797,981, with the lowest UNH revenue forecast at $239,651,782,507,752, and the highest UNH revenue forecast at $245,582,872,042,900. On average, 8 Wall Street analysts forecast UNH's revenue for 2021 to be $264,629,183,271,843, with the lowest UNH revenue forecast at $255,519,992,464,856, and the highest UNH revenue forecast at $274,103,488,806,546.
In 2022, UNH is forecast to generate $287,733,624,615,537 in revenue, with the lowest revenue forecast at $275,219,257,290,649 and the highest revenue forecast at $298,320,359,390,116.
What is UNH's Earnings Per Share (EPS) forecast for 2020-2022?
(NYSE: UNH) Unitedhealth Group's current Earnings Per Share (EPS) is $18.01. On average, analysts forecast that UNH's EPS will be $16.78 for 2020, with the lowest EPS forecast at $16.65, and the highest EPS forecast at $17.14. On average, analysts forecast that UNH's EPS will be $18.34 for 2021, with the lowest EPS forecast at $17.00, and the highest EPS forecast at $18.75. In 2022, UNH's EPS is forecast to hit $20.86 (min: $19.75, max: $21.25).
What is UNH's forecast return on equity (ROE) for 2020-2022?
(NYSE: UNH) forecast ROE is 31.08%, which is considered strong.
What is UNH's forecast return on assets (ROA) for 2020-2022?
(NYSE: UNH) forecast ROA is 10.27%, which is higher than the forecast US Healthcare industry average of 7.59%.
©2020 WallStreetZen
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
